Article Information
- Received November 20, 2013
- Revision received January 2, 2014
- Accepted January 18, 2014
- First published February 26, 2014.
- Version of record published February 26, 2014.
Author Information
- Daniel J. Foster1,2,
- Patrick R. Gentry1,2,
- Jose E. Lizardi-Ortiz3,
- Thomas M. Bridges1,2,4,
- Michael R. Wood1,2,4,5,
- Colleen M. Niswender1,2,4,
- David Sulzer3,
- Craig W. Lindsley1,2,4,5,
- Zixiu Xiang1,2, and
- P. Jeffrey Conn1,2,4
- 1Department of Pharmacology and
- 2Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee 37232,
- 3Departments of Neurology, Psychiatry, and Pharmacology, Columbia University, New York, New York, 10032,
- 4Vanderbilt Specialized Chemistry Center for Probe Development, Nashville, Tennessee 37232, and
- 5Department of Chemistry, Vanderbilt University, Nashville, Tennessee 37232
Author contributions
Author contributions: D.J.F., P.R.G., J.E.L.-O., D.S., Z.X., and P.J.C. designed research; D.J.F. and P.R.G. performed research; D.J.F., P.R.G., J.E.L.-O., T.M.B., M.R.W., C.M.N., C.W.L., Z.X., and P.J.C. analyzed data; D.J.F., J.E.L.-O., D.S., and P.J.C. wrote the paper.
Disclosures
- Received November 20, 2013.
- Revision received January 2, 2014.
- Accepted January 18, 2014.
This work was supported by the National Institutes of Health (Grants R01 MH073676 and F32 MH095285), the Udall Center of Excellence for Parkinson's Disease Research (Grants P50 NS071669 and P50 NS038370), the JPB Foundation, and the Parkinson's Disease Foundation. We thank H. Plumley for technical support.
Over the past year, C.W.L. consulted for Abbott and P.J.C. consulted for Pfizer. C.W.L. and P.J.C. also receive research support that includes salary support from Bristol Myers Squibb and Astra Zeneca and are inventors on multiple composition of matter patents protecting allosteric modulators of GPCRs. The remaining authors declare no competing financial interests.
- Correspondence should be addressed to Jeffrey Conn, Vanderbilt University Medical Center, 1205 Light Hall, Nashville, TN 37232-0697. Jeffrey.Conn{at}Vanderbilt.edu
Online Impact